RETURN
OF PROXIES
Whether
or not you plan to attend, it is important that your shares be represented
and voted at the annual meeting. To ensure your representation at the
annual meeting, a proxy card and business reply envelopes are enclosed for
your use. We urge each stockholder to vote promptly by signing and
returning his or her proxy card, regardless of the number of shares
held. The giving of a proxy will not affect your right to vote
in person if you attend the annual
meeting.
|
Name
and Address of
Beneficial
Owner
|
Amount
and Nature of
Beneficial
Ownership
|
Percent
of Class
|
|
Dr.
Alfred R. Globus
26-53
210th Street
Bayside,
NY 11360
|
1,202,484
|
(1)
|
24.3%
|
Kenneth
H. Globus
19
McCulloch Dr.
Dix
Hills, NY 11746
|
876,553
|
(2)
|
17.7%
|
Dr.
Betsee Parker
P.O.
Box 2198
Middleburg,
VA 20118
|
556,339
|
(3)
|
11.2%
|
(1)
|
Includes
1,151,240 shares held directly and 51,244 shares held beneficially as
follows: 14,966 shares owned by the Foundation for Science and Theology
Inc. of which Dr. Globus is President and Director; 35,500 shares held by
his wife; 658 shares controlled as Executor of the estate of Florence
Globus; and 120 shares held as legal guardian for his
son.
|
(2)
|
Includes
533,053 shares held directly and 343,500 shares held beneficially as
follows: 266,500 as Trustee; and 77,000 held by his
wife.
|
(3)
|
These
shares were formerly owned by her deceased husband, Mr. Irwin
Uran. Since Mr. Uran’s death in June 2007, the Company has
been advised by his widow, Dr. Betsee Parker, that she is the beneficial
owner of such shares and that she has sole voting and investment power
over those shares.
|
Name of Beneficial Owner |
Amount
and Nature of
Beneficial
Ownership
|
Percent of Class | ||
Dr.
Alfred R. Globus
|
1,202,484
|
(1)
|
24.3%
|
|
Henry
P. Globus
|
1,140
|
*
|
||
Robert
S. Rubinger
|
5,137
|
*
|
||
Kenneth
H. Globus
|
876,553
|
(2)
|
17.7%
|
|
Lawrence
F. Maietta
|
4,000
|
*
|
||
Arthur
M. Dresner
|
11,000
|
*
|
||
Andrew
A. Boccone
|
0
|
*
|
||
Christopher
W. Nolan, Sr.
|
0
|
*
|
||
All
Officers and Directors as a group (12 persons)
|
2,120,432
|
(1)
(2)
|
42.9%
|
*
|
Less
than one percent (1%)
|
(1)
|
Includes
1,151,240 shares held directly and 51,244 shares held beneficially as
follows: 14,966 shares owned by the Foundation for Science and Theology
Inc. of which Dr. Globus is President and Director; 35,500 shares held by
his wife; 658 shares controlled as Executor of the estate of Florence
Globus; and 120 shares held as legal guardian for his
son.
|
(2)
|
Includes
533,053 shares held directly and 343,500 shares held beneficially as
follows: 266,500 as Trustee; and 77,000 shares held by his
wife.
|
Plan
Category
|
Number
of securities to be issued upon exercise of outstanding options, warrants
and rights
(a)
|
Weighted-average
exercise price of
outstanding
options,
warrants
and rights
(b)
|
Number
of securities remaining available for future issuance
under
equity compensation plans (excluding securities reflected in column
(a))
(c)
|
Equity
compensation
plans
approved by
security
holders
|
|||
2004
Stock Option Plan
|
0
|
0
|
500,000
|
Equity
compensation
plans
not approved
by
security holders
|
|||
None
|
0
|
0
|
0
|
Total
|
0
|
0
|
500,000
|
Name
and Position
with the
Company
|
Age |
Principal
Occupation During the Past Five Years
|
Year
First
Elected
a
Director
|
Dr.
Alfred R. Globus
Chairman
of the Board of Directors and Director of Research
|
88
|
Chairman
of the Board and Director of Research of the Company since 1942. From 1988
to December 2006 Chief Executive Officer of the Company, and from 1942 to
1988 President of the Company.
|
1942
|
Henry
P. Globus
Director
|
86
|
From
July 1988 to date, business consultant to the Company. For more than 5
years prior thereto, Executive Vice President of the
Company.
|
1947
|
Robert
S. Rubinger
Executive
Vice President, Secretary, Chief Financial Officer and
Director
|
66
|
From
July 1988 to date, Executive Vice President and Secretary of the Company.
Treasurer of the Company from May 1994 to May 2004, and Chief Financial
Officer of the Company from December 2006 to date.
|
1982
|
Kenneth
H. Globus
President,
General Counsel and Director
|
57
|
From
July 1988 to date, President and General Counsel of the
Company. Chief Financial Officer of the Company from November
1997 to December 2006.
|
1984
|
Lawrence
F. Maietta
Director
|
51
|
Partner
in the accounting firm of Bonamassa, Maietta & Cartelli, LLP,
Brooklyn, NY, since October 1991. Controller of the Company from October
1991 to November 1997.
|
1994
|
Arthur
M. Dresner
Director
|
67
|
Counsel
to the law firm of Duane Morris LLP, New York, NY, since August 2007. From
1998 to 2007 partner and previously “Of Counsel” to the law firm of Reed
Smith, LLP, New York, NY (and its predecessor McAulay, Nissen, Goldberg
& Kiel LLP). For more than five years prior thereto, Vice President in
corporate development and general management of International Specialty
Products, Inc., Wayne, NJ.
|
1997
|
Andrew
A. Boccone
Director
|
63
|
Independent
business consultant since 2001. From 1990 until 2001, President of Kline
& Company, Inc., Little Falls, NJ, an international business
consulting and market research firm.
|
2002
|
Christopher
W. Nolan, Sr.
Director
|
44
|
Managing
Director since March 2006 and Executive Director from 2002 to 2006 in
Mergers and Acquisitions (M&A) for Rabobank International (and a
subsidiary), New York, NY. From 2000 to 2002 V.P. in M&A for Deutsche
Bank Securities, Inc., New York, NY. From 1992 to 2000, V.P., Corporate
Development and Investor Relations of International Specialty Products,
Inc., Wayne, NJ. Since June 2007, a Director and Audit
Committee member of Escala Group, Inc., Bethel, CT, a publicly traded
global collectibles network.
|
2005
|
Name
and Position
with the
Company
|
Age
|
Principal
Occupation During the Past Five Years
|
Dr.
Alfred R. Globus
Chairman
of the Board of Directors and Director of Research
|
88
|
From
1942 to date, Chairman of the Board and Director of Research of the
Company. From 1988 to December 2006, Chief Executive Officer of the
Company, and from 1942 to 1988 President of the
Company.
|
Kenneth
H. Globus
President,
General Counsel and Director
|
57
|
From
July 1988 to date, President and General Counsel of the Company. Chief
Financial Officer of the Company from November 1997 to December
2006.
|
Robert
S. Rubinger
Executive
Vice President, Secretary, Chief Financial Officer and
Director
|
66
|
From
July 1988 to date, Executive Vice President and Secretary of the Company.
Treasurer of the Company from May 1994 to May 2004. Chief Financial
Officer of the Company from December 2006 to date.
|
Charles
W. Castanza
Senior
Vice President
|
76
|
From
March 2000 to date, Senior Vice President of the Company. For more than 5
years prior thereto, Vice President and Operations Manager of Chemicals
& Pharmaceuticals of the Company. A director of the Company from 1982
to 2006.
|
Joseph
J. Vernice
Vice
President
|
51
|
From
February 1995 to date, Vice President of the Company. Since 1988 Manager
of Research & Development of the Company and since 1991 Director of
Technical Services of the Company.
|
Peter
A. Hiltunen
Vice
President
|
50
|
From
July 2002 to date, Vice President of the Company. Since 1982 Production
Manager of the Company.
|
Cecile
M. Brophy
Controller
|
60
|
From
May 2004 to date, Treasurer of the Company. From November 1997 to date,
Controller of the Company. From May 1994 until November 1997, Accounting
Manager of the
Company.
|
/s/ Arthur M. Dresner | /s/ Andrew A. Boccone | /s/ Christopher W. Nolan, Sr. |
Name
and principal position
|
Year
|
Salary
($)
|
Bonus
($)
|
Stock
awards ($)
|
Option
awards ($)
|
Nonequity
incentive plan compensation
($)
|
Nonqualified
deferred compensa-tion earnings
($)
|
All
other compen-sation*
($)
|
Total
($)
|
Alfred
R. Globus. Chairman of the Board
|
2007
|
150,068
|
8,000
|
-
|
-
|
-
|
-
|
-
|
158,068
|
2008
|
154,109
|
10,000
|
-
|
-
|
-
|
-
|
-
|
164,109
|
|
Kenneth
H. Globus,
President (Principal
Executive Officer)
|
2007
|
225,297
|
58,000
|
-
|
-
|
-
|
-
|
6,897*
|
290,194
|
2008
|
240,989
|
75,000
|
-
|
-
|
-
|
-
|
10,402*
|
326,391
|
|
Robert
S. Rubinger,
Executive
Vice
President
and Chief Financial Officer
|
2007
|
156,609
|
14,000
|
-
|
-
|
-
|
-
|
4,980*
|
175,589
|
2008
|
159,410
|
18,200
|
-
|
-
|
-
|
-
|
6,965*
|
184,575
|
*
|
In
2007 under its 401(k) Plan for all of its employees, the Company made a
contribution of up to 3% of each employee's pay for an employee's elective
deferral of 6% of pay. In 2008 the Company made a contribution of up to 4%
of each employee’s pay for an employee’s elective deferral of 4% of pay.
These amounts represent the Company's contribution for the
year.
|
Name
|
Fees
earned or paid in
cash
($)
|
Stock
awards ($)
|
Option
awards ($)
|
Non-Equity
incentive
plan
compensation
($)
|
Nonqualified
deferred compensation earnings
($)
|
All
other compensation ($)
|
Total
($)
|
Henry
P. Globus
|
14,000
|
-
|
-
|
-
|
-
|
21,816
(1)
|
35,816
|
Lawrence
F. Maietta
|
19,250
|
-
|
-
|
-
|
-
|
10,500
(2)
|
29,750
|
Arthur
M. Dresner
|
23,250
|
-
|
-
|
-
|
-
|
-
|
23,250
|
Andrew
A. Boccone
|
20,500
|
-
|
-
|
-
|
-
|
-
|
20,500
|
Christopher
W. Nolan, Sr.
|
18,250
|
-
|
-
|
-
|
-
|
-
|
18,250
|
(1)
|
Consulting
fee in accordance with a post-retirement agreement under which Henry P.
Globus provides consulting services to the Company related to his prior
responsibilities as Executive Vice President. Currently, he receives a fee
of $1,858/month, which is adjusted annually based on the cost of living
index. In addition, he receives medical and dental benefits equivalent to
those provided to officers of the
Company.
|
(2)
|
Consulting
fee paid to Bonamassa, Maietta & Cartelli, LLP for reviewing quarterly
and annual financial statements and corporate tax
returns.
|
THE
COMPANY WILL FURNISH, WITHOUT CHARGE, A COPY OF ITS ANNUAL REPORT ON FORM
10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2008, INCLUDING FINANCIAL
STATEMENTS AND FINANCIAL STATEMENT SCHEDULES, BUT EXCLUDING EXHIBITS, TO
EACH STOCKHOLDER WHO REQUESTS THE 10-K IN WRITING ADDRESSED TO: ROBERT S. RUBINGER, CORPORATE
SECRETARY, UNITED-GUARDIAN, INC., P. O. BOX 18050, HAUPPAUGE, NEW YORK
11788.
|